Investor Insights

This summary was created by AI, based on 2 opinions in the last 12 months.

Based on the reviews from different experts, it can be concluded that Marsh & McLennan (MMC-N) is a strong company with a diverse portfolio, including reinsurance and consulting businesses. Analysts expect double-digit returns over the cycle, and the recent acquisition adds to its potential growth. The company has consistently earned good reviews, making it a promising investment opportunity for both short-term and long-term gains.

Consensus
Positive
Valuation
Fair Value
TOP PICK
Marsh & McLennan

Their reinsurance business increases when premiums increase. Also operate consulting businesses. Recently bought it. Expects double-digit returns over the cycle.

(Analysts’ price target is $201.35)
insurance
PARTIAL BUY
Marsh & McLennan

It consistently earns, a good company. Buy some now and buy some more cheaper.

insurance
DON'T BUY
Marsh & McLennan
Insurance brokerage business is profitable, but technology will depress margins. Well run, but has benefited from PE expansion. Hard to see the upside. Great company, but rather fully priced.
insurance
PAST TOP PICK
Marsh & McLennan
(A Top Pick Apr 22/19, Down 7%) If you can get this at $64 he would be very happy.
insurance
PAST TOP PICK
Marsh & McLennan
(A Top Pick Apr 22/19, Up 21%) It could pull back to 101.60 but he would be a buyer in another $10 dollars.
insurance
TOP PICK
Marsh & McLennan
Model price of $115.23 which is an 8% upside. This is a solid company. (Analysts’ price target is $106.06)
insurance
TOP PICK
Marsh & McLennan
$112.32 is his target. Low volatility. Has long owned this and done well with it. Days of rigging bids and price fixing are long behind them. (Analysts’ price target is $93.94)
insurance
SELL
Marsh & McLennan
(Market Call Minute.) Management is terrible. Margins are under pressure. Would buy Willis Group (WSH-N) instead.
insurance
BUY
Marsh & McLennan
Probably a pretty reasonable buy right now after their sale of the Putnam Group. By most measures, it is a little undervalued.
insurance
BUY
Marsh & McLennan
Has gone through a lot of problems in the last 6 months or so. Senior management has been let go and there is talk about people rigging their bidding for certain aspects. The component parts of their company are actually pretty good. New management has cleared up a lot of the issues and thinks there's a lot more upside in this company.
insurance
DON'T BUY
Marsh & McLennan
Has a hard time understanding exactly what's in it or what the new model will look like. Was extremely profitable. It threw off cash. Had a high ROE. There were things going on that increased the profitability. Would stand back on this one.
insurance
DON'T BUY
Marsh & McLennan
Model price is $34.64. Prefers other cheaper companies.
insurance
WAIT
Marsh & McLennan
Have seen earnings estimates fall because of the lack of business that they were going to be getting. Using last Sept's balance sheet, feel that it is worth around $33.45. Want to see the write offs before buying.
insurance
DON'T BUY
Marsh & McLennan
Is in difficulty. Don't know what the underlying business is going to transform to. Also has a credibility issue.
insurance
DON'T BUY
Marsh & McLennan
Is in difficulty. Don't know what the underlying business is going to transform to. Also has a credibility issue.
insurance
Showing 1 to 15 of 22 entries

Marsh & McLennan(MMC-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Marsh & McLennan is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Marsh & McLennan(MMC-N) Frequently Asked Questions

What is Marsh & McLennan stock symbol?

Marsh & McLennan is a American stock, trading under the symbol MMC-N on the New York Stock Exchange (MMC). It is usually referred to as NYSE:MMC or MMC-N

Is Marsh & McLennan a buy or a sell?

In the last year, 1 stock analyst published opinions about MMC-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Marsh & McLennan.

Is Marsh & McLennan a good investment or a top pick?

Marsh & McLennan was recommended as a Top Pick by on . Read the latest stock experts ratings for Marsh & McLennan.

Why is Marsh & McLennan stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Marsh & McLennan worth watching?

1 stock analyst on Stockchase covered Marsh & McLennan In the last year. It is a trending stock that is worth watching.

What is Marsh & McLennan stock price?

On 2024-02-23, Marsh & McLennan (MMC-N) stock closed at a price of $203.65.